THERAPEUTIC AGENT FOR URINARY INCONTINENCE

摘要

PROBLEM TO BE SOLVED: To obtain the subject therapeutic agent having lowering action of pressure in bladder due to direct relaxation of vesical smooth muscle and especially effective to urinary incontinence due to abdominal pressure and impending incontinence by including formoterol and its salt as active ingredients. SOLUTION: This therapeutic agent contains formoterol (3-formylamino-4- hydroxy-α-[N-(1-methyl-2-p-methoxyphenylethyl)aminomethyl]benzyl allcohol) and/or its salt (especially preferably an acid addition salt of fumaric acid) as an active ingredient. The agent is preferably each administered at a dose of 2-1,000μg/man/time in the case of intravenous injection and at a divided dose of 10-1,000μg/man/kg once to three times per day in the case of oral administration and at a divided dose of 10-14,000μg/man/skin once to 7 times per day in the case of dermal administration. The therapeutic agent enables treatment of almost urinary incontinences which are different in symptom thereby.